Δημοσιεύσεις

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 43 results:
Συντάκτης Τίτλος [ Τύπος(Desc)] Έτος
Φίλτρα: Συντάκτης is Sinakos, Emmanouil  [Clear All Filters]
Journal Article
Papalavrentios, L., Sinakos E., Chourmouzi D., Hytiroglou P., Drevelegas K., Drevelegas A., et al. (2013).  3 Tesla diffusion-weighted MRI for assessing liver fibrosis in nonalcoholic fatty liver disease.. Hepatology. 58(1), 449-50.
Soulaidopoulos, S., Sinakos E., Dimopoulou D., Vettas C., Cholongitas E., & Garyfallos A. (2017).  Anticholinergic syndrome induced by toxic plants.. World J Emerg Med. 8(4), 297-301.
Papachrysos, N., Hytiroglou P., Papalavrentios L., Sinakos E., Kouvelis I., & Akriviadis E. (2015).  Antiviral therapy leads to histological improvement of HBeAg-negative chronic hepatitis B patients.. Ann Gastroenterol. 28(3), 374-378.
Papachrysos, N., Hytiroglou P., Papalavrentios L., Sinakos E., Kouvelis I., & Akriviadis E. (2015).  Authors' reply.. Ann Gastroenterol. 28(4), 507.
Sinakos, E., Marschall H-U., Kowdley K. V., Befeler A., Keach J., & Lindor K. (2010).  Bile acid changes after high-dose ursodeoxycholic acid treatment in primary sclerosing cholangitis: Relation to disease progression.. Hepatology. 52(1), 197-203.
Sinakos, E., & Lindor K. D. (2010).  Bile acid profiles in intrahepatic cholestasis of pregnancy: is this the solution to the enigma of intrahepatic cholestasis of pregnancy?. Am J Gastroenterol. 105(3), 596-8.
Kiapidou, S., Liava C., Kalogirou M., Akriviadis E., & Sinakos E. (2020).  Chronic kidney disease in patients with non-alcoholic fatty liver disease: What the Hepatologist should know?. Ann Hepatol. 19(2), 134-144.
Fotiadu, A., Gagalis A., Akriviadis E., Kotoula V., Sinakos E., Karkavelas G., et al. (2010).  Clinicopathological correlations in a series of adult patients with non-alcoholic fatty liver disease.. Pathol Int. 60(2), 87-92.
Thackeray, E. W., Charatcharoenwitthaya P., Elfaki D., Sinakos E., & Lindor K. D. (2011).  Colon neoplasms develop early in the course of inflammatory bowel disease and primary sclerosing cholangitis.. Clin Gastroenterol Hepatol. 9(1), 52-6.
Malandris, K., Papandreou S., Avgerinos I., Karagiannis T., Paschos P., Michailidis T., et al. (2023).  Comparative efficacy of glucose-lowering drugs on liver steatosis as assessed by means of magnetic resonance imaging in patients with type 2 diabetes mellitus: systematic review and network meta-analysis.. Hormones (Athens). 22(4), 655-664.
Cholongitas, E., Ioannidou M., Goulis I., Chalevas P., Ntogramatzi F., Athanasiadou Z., et al. (2017).  Comparison of creatinine and cystatin formulae with Chromium-ethylenediaminetetraacetic acid glomerular filtration rate in patients with decompensated cirrhosis.. J Gastroenterol Hepatol. 32(1), 191-198.
Louvet, A., Thursz M. R., Kim D. Joon, Labreuche J., Atkinson S. R., Sidhu S. Singh, et al. (2018).  Corticosteroids Reduce Risk of Death Within 28 Days for Patients With Severe Alcoholic Hepatitis, Compared With Pentoxifylline or Placebo-a Meta-analysis of Individual Data From Controlled Trials.. Gastroenterology. 155(2), 458-468.e8.
Sousos, N., Sinakos E., Klonizakis P., Adamidou D., Daniilidis A., Gigi E., et al. (2018).  Deferasirox improves liver fibrosis in beta-thalassaemia major patients. A five-year longitudinal study from a single thalassaemia centre.. Br J Haematol. 181(1), 140-142.
Oikonomou, I. Marios, Sinakos E., Antoniadis N., Goulis I., Giouleme O., Anifanti M., et al. (2022).  Effects of an active lifestyle on the physical frailty of liver transplant candidates.. World J Transplant. 12(11), 365-377.
Katsanos, G., Karakasi K-E., Antoniadis N., Vasileiadou S., Kofinas A., Morsi-Yeroyannis A., et al. (2022).  Enhanced recovery after surgery in liver transplantation: Challenges and feasibility.. World J Transplant. 12(7), 195-203.
Gigi, E., Sinakos E., Sykja A., Androulakis G., Tanis C., Stayridou V., et al. (2013).  Epidemiology, clinical data, and treatment of viral hepatitis in a large cohort of intravenous drug users.. J Addict Med. 7(1), 52-7.
Protopapas, A. A., Papagiouvanni I., Fragkou N., Alevroudis E., Sinakos E., & Goulis I. (2020).  Estimation of glomerular filtration rate in patients with cirrhosis: evaluation of equations currently used in clinical practice and validation of Royal Free Hospital cirrhosis glomerular filtration rate.. Eur J Gastroenterol Hepatol.
Sinakos, E., Hytiroglou P., Chourmouzi D., & Akriviadis E. (2015).  Focal nodular hyperplasia in an individual with Abernethy malformation type 1b.. Dig Liver Dis. 47(12), 1089.
Chourmouzi, D., Sinakos E., Papalavrentios L., Akriviadis E., & Drevelegas A. (2009).  Gastrointestinal stromal tumors: a pictorial review.. J Gastrointestin Liver Dis. 18(3), 379-83.
Eaton, J. E., Silveira M. G., Pardi D. S., Sinakos E., Kowdley K. V., Luketic V. A. C., et al. (2011).  High-dose ursodeoxycholic acid is associated with the development of colorectal neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis.. Am J Gastroenterol. 106(9), 1638-45.
Sinakos, E., Samuel S., Enders F., Loftus E. V., Sandborn W. J., & Lindor K. D. (2013).  Inflammatory bowel disease in primary sclerosing cholangitis: a robust yet changing relationship.. Inflamm Bowel Dis. 19(5), 1004-9.
Sinakos, E., Perifanis V., Vlachaki E., Tsatra I., & Raptopoulou-Gigi M. (2010).  Is liver stiffness really unrelated to liver iron concentration?. Br J Haematol. 150(2), 247-8.
Imam, M. H., Silveira M. G., Sinakos E., Gossard A. A., Jorgensen R., Keach J., et al. (2012).  Long-term outcomes of patients with primary biliary cirrhosis and hepatocellular carcinoma.. Clin Gastroenterol Hepatol. 10(2), 182-5.
Sinakos, E., Saenger A. K., Keach J., W Kim R., & Lindor K. D. (2011).  Many patients with primary sclerosing cholangitis and increased serum levels of carbohydrate antigen 19-9 do not have cholangiocarcinoma.. Clin Gastroenterol Hepatol. 9(5), 434-9.e1.
Sinakos, E., Antoniadis N., Goulis I., Cholongitas E., Kiapidou S., Tsakni E., et al. (2016).  Nucleos(t)ide analogues for the prevention of hepatitis B recurrence after liver transplantation do not affect serum phosphorus levels.. Ann Gastroenterol. 29(2), 208-13.

Σελίδες

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.

           

Σύνδεσμοι

 

Το πανεπιστήμιο

 
 

Προσωπικό & Φοιτητές